Skip to content

The function of lidorcaine in alleviating propofol injection pain via bilateral symmetrical veins of hands or a single vein

The function of lidorcaine in alleviating propofol injection pain via bilateral symmetrical veins of hands or a single vein

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-15006006
Enrollment
Unknown
Registered
2014-11-27
Start date
2015-01-08
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain

Interventions

A:2 ml saline is administrated via the biggest vein in the opisthenar of right hand followed by 2 mg/ Kg propofol though the same vein in 3 minutes
B:2 g lidocaine cream is wiped the opisthenar of right hand 1 hour before 2 mg/ Kg propofol is givwn
C:20 mg lidorcaine is administrated via the biggest vein in the opisthenar of right hand followed by 2 mg/ Kg propofol though the same vein in 3 minutes
D:40 mg lidorcaine is administrated via the biggest vein in the opisthenar of right hand followed by 2 mg/ Kg propofol though the same vein in 3 minutes
E:20 mg lidorcaine is administrated via the biggest vein in the opisthenar of left hand followed by 2 mg/ Kg propofol though symmetrical vein of right hand in 3 minutes
F:40 mg lidorcaine is administrated via the biggest vein in the opisthenar of left hand followed by 2 mg/ Kg propofol though symmetrical vein of right hand in 3 minutes

Sponsors

The third affiliated hospital of Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: The patients are aged 18 to 60; The American society of anesthesiologists (ASA) 1 or 2; Blood routine,whose biochemicalexamination and blood coagulation are mormal, no allergy history of local anesthetic, propofol, fentanyl; No peripheral vascular disease, no chronic pain syndrome, no mental or nervous system diseases.

Exclusion criteria

Exclusion criteria: The patients have accepted painkillers or other analgesia and sedative within 24 hours; Have accepted beta-blockers, vascular active drugs or cimetidine; Have accepted drugs that cannot be companyed with lidocaine, fentanyl and propofol.

Design outcomes

Primary

MeasureTime frame
verbal rating scale;

Secondary

MeasureTime frame
blood pressure, heart rate;recovery time;

Countries

China

Contacts

Public ContactHe Ziqin
Heiziqing@sina.com+86 13925020330

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026